Peroxisome proliferator-activated receptor β/δ agonist GW0742 ameliorates cerulein- and taurocholate-induced acute pancreatitis in mice

Surgery (United States)

Volumn 152, Issue 1, 2012, Pages 90-106

  Paterniti, Irene ^a   Mazzon, Emanuela ^a,b   Riccardi, Luisa ^a   Galuppo, Maria ^a   Impellizzeri, Daniela ^a   Esposito, Emanuela ^a   Bramanti, Placido ^b   Cappellani, Alessandro ^c   Cuzzocrea, Salvatore ^a,b  

^a UNIVERSITY OF MESSINA   (Italy)

^b IRCCS CENTRO NEUROLESI BONINO PULEJO   (Italy)

^c UNIVERSITY OF CATANIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; [4 [2 (3 FLUORO 4 TRIFLUOROMETHYLPHENYL) 4 METHYL 5 THIAZOLYLMETHYLTHIO] 2 METHYLPHENOXY]ACETIC ACID; AMYLASE; CERULETIDE; FAS LIGAND; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; MYELOPEROXIDASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PADGEM PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PROTEIN BAX; PROTEIN BCL 2; TAUROCHOLIC ACID; TRANSCRIPTION FACTOR RELA; TRIACYLGLYCEROL LIPASE; TUMOR NECROSIS FACTOR ALPHA;

ACUTE PANCREATITIS; AMYLASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; EDEMA; ENZYME ACTIVITY; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NEUTROPHIL CHEMOTAXIS; NICK END LABELING; NONHUMAN; ORGAN WEIGHT; PANCREAS NECROSIS; PANCREAS WEIGHT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TISSUE INJURY; TRIACYLGLYCEROL LIPASE BLOOD LEVEL; WATER CONTENT; WESTERN BLOTTING;

ACUTE DISEASE; AMYLASES; ANIMALS; CAERULEIN; CELL ADHESION MOLECULES; CELL MOVEMENT; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; LIPASE; MALE; MICE; MICE, INBRED STRAINS; NEUTROPHILS; PANCREATITIS; PPAR DELTA; PPAR-BETA; TAUROCHOLIC ACID; THIAZOLES; TIME FACTORS;

EID: 84862844548     PISSN: 00396060     EISSN: 15327361     Source Type: Journal    
DOI: 10.1016/j.surg.2012.02.004     Document Type: Article

References (46)

1. Tenenbaum A, Motro M, Fisman EZ. Dual and panperoxisome proliferator-activated receptors (PPAR) coagonism: the bezafibrate lessons. Cardiovasc Diabetol 2005;4:14.
2. Sheng L, Ye P, Liu YX, Han CG, Zhang ZY. Peroxisome proliferator- activated receptor beta/delta activation improves angiotensin II-induced cardiac hypertrophy in vitro. Clin Exp Hypertens 2008;30:109-19.
3. Stuart JM, Townes AS, Kang AH. Collagen autoimmune arthritis. Annu Rev Immunol 1984;2:199-218.
4. Holmdahl R, Andersson M, Goldschmidt TJ, Gustafsson K, Jansson L, Mo JA. Type II collagen autoimmunity in animals and provocations leading to arthritis. Immunol Rev 1990; 118:193-232.
5. Braissant O, Foufelle F, Scotto C, Dauca M, Wahli W. Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat. Endocrinology 1996;137: 354-66.
6. Amri EZ, Bonino F, Ailhaud G, Abumrad NA, Grimaldi PA. Cloning of a protein that mediates transcriptional effects of fatty acids in preadipocytes. Homology to peroxisome proliferator-activated receptors. J Biol Chem 1995;270: 2367-71.
7. Hertz R, Berman I, Keppler D, Bar-Tana J. Activation of gene transcription by prostacyclin analogues is mediated by the peroxisome- proliferators-activated receptor (PPAR). Eur J Biochem 1996;235:242-7.
8. Berger JP, Akiyama TE, Meinke PT. PPARs: therapeutic targets for metabolic disease. Trends Pharmacol Sci 2005;26: 244-51.
9. Desvergne B, Michalik L, Wahli W. Be fit or be sick: peroxisome proliferator-activated receptors are down the road. Mol Endocrinol 2004;18:1321-32.
10. Fredenrich A, Grimaldi PA. PPAR delta: an uncompletely known nuclear receptor. Diabetes Metab 2005; 31:23-7.
11. Lankisch PG, Ihse I. Bile-induced acute experimental pancreatitis. Scand J Gastroenterol 1987;22:257-60.
12. Steinberg W, Tenner S. Acute pancreatitis. N Engl J Med 1994;330:1198-210.
13. Brivet FG, Emilie D, Galanaud P. Pro- and anti-inflammatory cytokines during acute severe pancreatitis: an early and sustained response, although unpredictable of death. Parisian Study Group on Acute Pancreatitis. Crit Care Med 1999;27: 749-55.
14. Sparmann G, Behrend S, Merkord J, Kleine HD, Graser E, Ritter T, et al. Cytokine mRNA levels and lymphocyte infiltration in pancreatic tissue during experimental chronic pancreatitis induced by dibutyltin dichloride. Dig Dis Sci 2001;46:1647-56.
15. Emmrich J, Weber I, Nausch M, Sparmann G, Koch K, Seyfarth M, et al. Immunohistochemical characterization of the pancreatic cellular infiltrate in normal pancreas, chronic pancreatitis and pancreatic carcinoma. Digestion 1998;59: 192-8.
16. Lichtenstein A, Milani R Jr, Fernezlian SM, Leme AS, Capelozzi VL, Martins MA. Acute lung injury in two experimental models of acute pancreatitis: infusion of saline or sodium taurocholate into the pancreatic duct. Crit Care Med 2000;28:1497-502.
17. Pfutzer RH, Whitcomb DC. Acute pancreatitis. Curr Opin Gastroenterol 2000;16:410-3.
18. Galuppo M, Di Paola R, Mazzon E, Genovese T, Crisafulli C, Paterniti I, et al. Role of PPAR-delta in the development of zymosan-induced multiple organ failure: an experiment mice study. J Inflamm (Lond) 2010;7:12.
19. Di Paola R, Crisafulli C, Mazzon E, Esposito E, Paterniti I, Galuppo M, et al. GW0742, a high-affinity PPAR -beta/delta agonist, inhibits acute lung injury in mice. Shock 2010;33: 426-35.
20. Paterniti I, Esposito E, Mazzon E, Galuppo M, Di Paola R, Bramanti P, et al. Evidence for the role of peroxisome proliferator-activated receptor-beta/delta in the development of spinal cord injury. J Pharmacol Exp Ther 2010; 333:465-77.
21. Cuzzocrea S, Misko TP, Costantino G, Mazzon E, Micali A, Caputi AP, et al. Beneficial effects of peroxynitrite decomposition catalyst in a rat model of splanchnic artery occlusion and reperfusion. FASEB J 2000;14:1061-72.
22. Cuzzocrea S, Malleo G, Genovese T, Mazzon E, Esposito E, Muia C, et al. Effects of glycogen synthase kinase-3beta inhibition on the development of cerulein-induced acute pancreatitis in mice. Crit Care Med 2007;35:2811-21.
23. Galuppo M, Nocentini G, Mazzon E, Ronchetti S, Esposito E, Riccardi L, et al. The glucocorticoid-induced TNF receptor family-related protein (GITR) is critical to the development of acute pancreatitis in mice. Br J Pharmacol 2011; 162:1186-201.
24. Genovese T, Mazzon E, Di Paola R, Muia C, Crisafulli C, Menegazzi M, et al. Hypericum perforatum attenuates the development of cerulein-induced acute pancreatitis in mice. Shock 2006;25:161-7.
25. Babu BI, Malleo G, Genovese T, Mazzon E, Di Paola R, Crisafulli C, et al. Green tea polyphenols ameliorate pancreatic injury in cerulein-induced murine acute pancreatitis. Pancreas 2009;38:954-67.
26. Mullane KM, Kraemer R, Smith B. Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium. J Pharmacol Methods 1985; 14:157-67.
27. Cuzzocrea S, Genovese T, Mazzon E, Di Paola R, Muia C, Britti D, et al. Reduction in the development of ceruleininduced acute pancreatitis by treatment with M40401, a new selective superoxide dismutase mimetic. Shock 2004; 22:254-61.
28. Gukovskaya AS, Pandol SJ. Cell death pathways in pancreatitis and pancreatic cancer. Pancreatology 2004;4:567-86.
29. Delerive P, Fruchart JC, Staels B. Peroxisome proliferatoractivated receptors in inflammation control. J Endocrinol 2001;169:453-9.
30. Chinetti G, Fruchart JC, Staels B. Peroxisome proliferatoractivated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation. Inflamm Res 2000;49:497-505.
31. Griesbacher T, Pommer V, Schuligoi R, Tiran B, Peskar BA. Anti-inflammatory actions of perfluorooctanoic acid and peroxisome proliferator-activated receptors (PPAR) alpha and gamma in experimental acute pancreatitis. Int Immunopharmacol 2008;8:325-9.
32. Celinski K, Madro A, Prozorow-Krol B, Korolczuk A, Cichoz-Lach H, Slomka M, et al. Rosiglitazone, a peroxisome proliferator-activated receptor gamma (PPARgamma)-specific agonist, as a modulator in experimental acute pancreatitis. Med Sci Monit 2009;15:BR21-9.
33. Chen C, Xu S, Wang WX, Ding YM, Yu KH, Wang B, et al. Rosiglitazone attenuates the severity of sodium taurocholate-induced acute pancreatitis and pancreatitis-associated lung injury. Arch Med Res 2009;40:79-88.
34. Di Paola R, Esposito E, Mazzon E, Paterniti I, Galuppo M, Cuzzocrea S. GW0742, a selective PPAR-beta/delta agonist, contributes to the resolution of inflammation after gut ischemia/reperfusion injury. J Leukoc Biol 2010;88: 291-301.
35. Ding G, Cheng L, Qin Q, Frontin S, Yang Q. PPARdelta modulates lipopolysaccharide-induced TNFalpha inflammation signaling in cultured cardiomyocytes. J Mol Cell Cardiol 2006;40:821-8.
36. Frossard JL, Pastor CM, Hadengue A. Effect of hyperthermia on NF-kappaB binding activity in cerulein-induced acute pancreatitis. Am J Physiol Gastrointest Liver Physiol 2001;280:G1157-62.
37. Kim H, Seo JY, Kim KH. NF-kappaB and cytokines in pancreatic acinar cells. J Korean Med Sci 2000;15(Suppl):S53-4.
38. Jaffray C, Yang J, Carter G, Mendez C, Norman J. Pancreatic elastase activates pulmonary nuclear factor kappa B and inhibitory kappa B, mimicking pancreatitis-associated adult respiratory distress syndrome. Surgery 2000;128:225-31.
39. Rakonczay Z Jr, Jarmay K, Kaszaki J, Mandi Y, Duda E, Hegyi P, et al. NF-kappaB activation is detrimental in arginine-induced acute pancreatitis. Free Radic Biol Med 2003;34: 696-709.
40. Ghosh S, Karin M. Missing pieces in the NF-kappaB puzzle. Cell 2002;109(Suppl):S81-96.
41. Volman TJ, Hendriks T, Verhofstad AA, Kullberg BJ, Goris RJ. Improved survival of TNF-deficient mice during the zymosan-induced multiple organ dysfunction syndrome. Shock 2002;17:468-72.
42. Jansen MJ, Hendriks T, Hermsen R, Van der Meer JW, Goris RJ. A monoclonal antibody against tumour necrosis factor-alpha improves survival in experimental multiple organ dysfunction syndrome. Cytokine 1998;10:904-10.
43. Virlos I, Mazzon E, Serraino I, Di Paola R, Genovese T, Britti D, et al. Pyrrolidine dithiocarbamate reduces the severity of cerulein-induced murine acute pancreatitis. Shock 2003;20: 544-50.
44. Bowie A, O'Neill LA. Oxidative stress and nuclear factor-kappaB activation: a reassessment of the evidence in the light of recent discoveries. Biochem Pharmacol 2000;59: 13-23.
45. Cuzzocrea S, Pisano B, Dugo L, Ianaro A, Britti D, Patel NS, et al. Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-gamma, reduces acute pancreatitis induced by cerulein. Intensive Care Med 2004;30:951-6.
46. Gomez G, Lee HM, He Q, Englander EW, Uchida T, Greeley GH Jr. Acute pancreatitis signals activation of apoptosis-associated and survival genes in mice. Exp Biol Med (Maywood) 2001;226:692-700.